News
3 Reasons I've Been Aggressively Buying Intercept Pharmaceuticals
I admit it: I love trying to catch a falling knife. Sometimes you get sliced in the process, while at other times you leave vindicated by having gone against the grain. My belief is that small-cap....
How to Invest in Healthcare
Ten thousand Americans will turn 65 years old every day from now through 2029. As those Americans age, they will transform our country's healthcare system -- to the tune of a 5.8% annual increase....
ResMed's Sales and Profits Rise
ResMed (NYSE: RMD), a medical device marker focused on continuous positive airway pressure (CPAP) machines and accessories, reported its fiscal first-quarter results on Thursday, Oct. 26. The....
VISIOMED GROUP décroche la certification médicale européenne pour BewellCheck-up(R), la 1ère solution d'interprétation médicale et d'orientation diagnostique dotée d'Intelligence Artificielle
Paris, le 30 octobre 2017
VISIOMED GROUP (FR0011067669 – ALVMG), société spécialisée dans l'électronique médicale nouvelle génération, annonce que BewellCheck-up® vient de décrocher la....
3 Biotech Stocks That Turned $1,000 Into More Than $5,000 This Year
It's been a banner year for anyone who started 2017 holding shares of AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO), XOMA Corporation (NASDAQ: XOMA), or Dynavax Technologies Corporation (NASDAQ:....
5 Things You Need to Know From Gilead Sciences' Q3 Update
You could probably fit the number of people surprised by Gilead Sciences' (NASDAQ: GILD) third-quarter results inside a phone booth -- if you could even find one. Hepatitis C virus (HCV) drug....
Ending Obamacare's Cost-Sharing Reductions Will Lead to This Ironic Result
With open enrollment for the Affordable Care Act (ACA) just days away, you're liable to notice that Obamacare (the more common name for the ACA) will look a lot different in the upcoming year.Most....
A Me-Too Push By Biopharma Is Crowding the Psoriasis Market
A wave of R&D is leading to next-generation psoriasis drugs that work better than ever. That's great news for patients desperate for new treatment options, but it's bad news for biopharma....
3 Bright Spots in Merck's Q3 Results
You only had to look at Merck's (NYSE: MRK) stock movement to know that the big drugmaker's third-quarter results weren't too great. Merck's share price dropped after the company reported a 2%....
3 High-Yield Dividend Aristocrat Stocks
If dividend stocks were like golf, there would be an elite group of stocks with green jackets like golfing greats who win the Masters tournament get to wear. This group of winners is called the....
Vertex Pharmaceuticals Incorporated: One Eye on Earnings, One on the Pipeline
Vertex Pharmaceuticals (NASDAQ: VRTX) reported solid third-quarter earnings, with sales of its cystic fibrosis drugs up 34% year over year. Nevertheless, investors rightfully have one eye on the....
Celgene At $100: Buy, Sell, or Hold?
It's been a rotten couple of weeks to be a shareholder of Celgene (NASDAQ: CELG). The biotech giant's shares have been in near-freefall after they reached an all-time high of $147 on Oct. 2.....
3 Small-Cap Marijuana Stocks to Get on Your Radar
When it comes to the fastest-growing, and riskiest, industries in the stock market, none takes the cake like legal marijuana.According to cannabis research firm The Arcview Group, legal sales in....
Here's Why Endo International Stock Dropped as Much as 13.8% Today
Shares of generic pharma leader Endo International (NASDAQ: ENDP) sank nearly 14% today after the company announced two of its subsidiaries had filed a lawsuit against the U.S. Food and Drug....
Here's Why ResMed Inc. Stock Spiked Today
Sleep apnea specialist, ResMed, Inc. (NYSE: RMD) pleased investors with a positive fiscal first-quarter report after the bell yesterday. Another quarter of double-digit year-to-year growth on the....
Why Shares of Cerner Corp. Are Down Today
Shares of Cerner (NASDAQ: CERN), a provider of technology and solutions to the healthcare industry, slumped on Friday following the company's third-quarter report. Cerner missed analyst estimates....
Why LeMaitre Vascular Inc. Is Plunging Today
After the company reported third-quarter earnings, shares of LeMaitre Vascular (NASDAQ: LMAT), a medical device maker focused on vascular surgery, fell 18% as of 11:35 a.m. EDT on Friday.Here's an....
ALPHA MOS : CHIFFRE D'AFFAIRES NEUF MOIS 2017
En M€ - Normes IFRS
Données non auditées
2017
2016
Variation
Chiffre d'affaires 1er semestre
2,1
3,9
-47%
Chiffre d'affaires 3ème....
There's a Lot to Like in AbbVie's Q3 Update
AbbVie (NYSE: ABBV) has set a pattern in recent quarters of meeting or barely exceeding consensus analysts' earnings estimates. It's not that the big biotech hasn't performed well; rather,....
Quintiles IMS Holdings Is Firing on All Cylinders
Quintiles IMS Holdings (NYSE: Q), a service and information provider for the healthcare and life sciences industries, reported its third-quarter results on Thursday, Oct. 26. The company's results....
What's Causing Align Technology's Shares to Soar 14% Today
After reporting third-quarter financial results that beat industry watchers expectations, shares in Align Technology (NASDAQ: ALGN) are surging 14.1% higher at 11:30 a.m. EDT.Years of double-digit....
Cerner Corporation Unimpressive in 3rd Quarter, but Expects Better Days Ahead
Cerner Corporation (NASDAQ: CERN) started off 2017 with a bang, posting strong revenue and earnings growth in the first quarter. Things slowed down a bit in the second quarter, with the healthcare....
3 Key Things to Watch in Pfizer's Q3 Results
There wasn't much to get excited about the last time Pfizer (NYSE: PFE) reported its quarterly results. While the big pharma company beat analysts' consensus earnings estimate, it also posted a 2%....
Stop Panicking About Celgene
Judging by the market reaction to Celgene's (NASDAQ: CELG) third-quarter results, you'd think one of the Four Horsemen of the Apocalypse just rode down Wall Street. Or maybe two of them....
Align Technology Inc.'s 2017 Is Lining Up Nicely With Another Record Quarter
Align Technology (NASDAQ: ALGN) posted record-high revenue when it announced its first-quarter results earlier this year. The medical-device company, best known for its Invisalign clear aligners,....